Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts — VialBase Research
high
- BPC-157 increases growth hormone receptor expression in tendon fibroblasts
- Promotes tendon fibroblast growth and migration
- Suggests a GH-receptor-mediated mechanism for tendon healing
Summary
This in-vitro study investigated the effects of BPC-157 on growth hormone receptor (GHR) expression in human tendon fibroblasts. The researchers found that BPC-157 significantly upregulates GHR expression, promoting fibroblast proliferation and migration — key processes in tendon repair.
Key Findings
- BPC-157 significantly increases GHR expression in tendon fibroblasts in a dose-dependent manner
- Enhanced fibroblast proliferation observed at therapeutic concentrations
- Increased cell migration, suggesting enhanced wound-healing capacity
- Proposes a molecular mechanism linking BPC-157 to musculoskeletal healing via GH signaling
- Effects observed at nanomolar concentrations relevant to therapeutic dosing
Methodology
In-vitro study using cultured human tendon fibroblasts. Cells were treated with varying concentrations of BPC-157. GHR expression was measured via Western blot and RT-PCR. Cell proliferation assessed by MTT assay and migration by wound-healing scratch assay.
Limitations
- In-vitro study — results may not directly translate to in-vivo conditions
- Single cell type studied (tendon fibroblasts only)
- Does not account for systemic factors present in whole-organism healing
- Limited exploration of downstream signaling pathways
Relevance to Content
Important mechanistic study that helps explain how BPC-157 promotes musculoskeletal healing. The GH receptor connection is relevant for content discussing BPC-157’s synergy with growth hormone or growth hormone secretagogues (e.g., CJC-1295/Ipamorelin stacks). Useful for articles explaining BPC-157 mechanisms of action beyond simple “healing peptide” descriptions.
See Also
- Parent compound: BPC-157